SuperworthInMed Pharmaceuticals market cap INM
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $7.9M
- Highest close in our data
- $37.3M
- Feb 2021
InMed Pharmaceuticals is worth $7.9M at the close on Oct 23, 2026, at $1.44 a share.
That is up 60% over the last year and down 45% over five years.
Its highest close in our data was $37.3M in Feb 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $7.9M | $1.9M | $7.9M | +131% |
| 2025 | $3.4M | $2.2M | $5.5M | +1% |
| 2024 | $3.4M | $1.2M | $4.4M | +56% |
| 2023 | $2.2M | $1.3M | $4.6M | +16% |
| 2022 | $1.9M | $1.2M | $18.1M | −90% |
| 2021 | $18.5M | $13.1M | $37.3M | −20% |
| 2020 | $23M | $22M | $23M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest InMed Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| INMInMed Pharmaceuticals | $7.9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on InMed Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.